VRTX
VRTX
NASDAQ · Biotechnology

Vertex Pharmaceuticals Inc

S&P 500 Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$527.67
+1.48 (+0.28%)
As of Sep 28, 9:31 PM ET ·
Analyst Consensus
Strong Buy
36
Analysts
Very High
Coverage
Buy 29 81%
Hold 6 17%
Sell 1 3%
Price Target
Analyst Price Target -16.9% upside
Low Target $313.95
Average Target $438.34
High Target $454.41
Current Price $527.67
Current
$527.67
Target
$438.34
$313.95 $438.34 avg $454.41
Scenario Analysis
Bear Case
$313.95
-40.5%
Low target
Base Case
$438.34
-16.9%
Avg target
Bull Case
$454.41
+-13.9%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$560.25
-5.8% from high
52-Week Low
$374.17
+41.0% from low
50-Day SMA
$461.14
+14.4% vs SMA
200-Day SMA
$435.10
+21.3% vs SMA
RSI (14)
47.3
Neutral
Target vs 52W High
$438.34
-21.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -43.4%